Zivo Bioscience (OTCMKTS:ZIVO) and Simply Good Foods (NASDAQ:SMPL) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, institutional ownership, risk, profitability and earnings.

Institutional & Insider Ownership

0.1% of Zivo Bioscience shares are owned by institutional investors. Comparatively, 84.4% of Simply Good Foods shares are owned by institutional investors. 33.2% of Zivo Bioscience shares are owned by company insiders. Comparatively, 4.6% of Simply Good Foods shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Volatility and Risk

Zivo Bioscience has a beta of 2.41, meaning that its share price is 141% more volatile than the S&P 500. Comparatively, Simply Good Foods has a beta of 0.68, meaning that its share price is 32% less volatile than the S&P 500.

Profitability

This table compares Zivo Bioscience and Simply Good Foods’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Zivo Bioscience N/A N/A -771.46%
Simply Good Foods 16.33% 6.73% 4.56%

Earnings and Valuation

This table compares Zivo Bioscience and Simply Good Foods’ gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Zivo Bioscience N/A N/A -$10.03 million N/A N/A
Simply Good Foods $431.43 million 3.49 $70.45 million $0.58 32.12

Simply Good Foods has higher revenue and earnings than Zivo Bioscience.

Analyst Ratings

This is a summary of current ratings for Zivo Bioscience and Simply Good Foods, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Zivo Bioscience 0 0 0 0 N/A
Simply Good Foods 0 0 6 0 3.00

Simply Good Foods has a consensus price target of $18.75, indicating a potential upside of 0.64%. Given Simply Good Foods’ higher possible upside, analysts plainly believe Simply Good Foods is more favorable than Zivo Bioscience.

Summary

Simply Good Foods beats Zivo Bioscience on 8 of the 10 factors compared between the two stocks.

About Zivo Bioscience

Zivo Bioscience, Inc., together with its subsidiaries, focuses on the research and identification of natural bioactive ingredients derived from its proprietary algal cultures. The company intends to license and sell its natural bioactive ingredients to animal, food, dietary supplement, and medical food manufacturers; and license its bioactive molecules as lead compounds or templates for synthetic variants intended for therapeutic applications. It is also involved in developing, manufacturing, marketing, and selling tests that allow individuals to optimize their health and identify future health risks, as well as provides insurers, employers, and healthcare providers with timely information to intervene with wellness programs, fitness regimes, or other preventative measures. The company was formerly known as Health Enhancement Products, Inc. and changed its name to Zivo Bioscience, Inc. in November 2014. Zivo Bioscience, Inc. is headquartered in Keego Harbor, Michigan.

About Simply Good Foods

The Simply Good Foods Company develops, markets, and sells branded nutritional foods and snack products in North America and internationally. It markets nutrition bars, ready-to-drink shakes, snacks, and confectionery products under the Atkins, SimplyProtein, Atkins Harvest Trail, and Atkins Endulge brand names. The company is headquartered in Denver, Colorado.

Receive News & Ratings for Zivo Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zivo Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.